Risk factors of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

被引:6
|
作者
Torre-Cisneros, Julian [2 ]
Tejero Garcia, Rocio [1 ]
Natera Kindelan, Clara [2 ]
Font Ugalde, Pilar [2 ]
Franco Alvarez de Luna, Francisco [1 ]
Caston Osorio, Juan Jose [2 ]
Rivero Roman, Antonio [2 ]
Casal Roman, Manuel [1 ]
机构
[1] Hosp Univ Reina Sofia, Microbiol Serv, Cordoba, Spain
[2] Hosp Univ Reina Sofia, Unidad Clin Enfermedades Infecciosas, Cordoba, Spain
来源
MEDICINA CLINICA | 2012年 / 138卷 / 03期
关键词
Infection; Respiratory; Bacterial; Staphylococcus aureus; Nosocomial; VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; 2; DOUBLE-BLIND; INFECTIONS; VANCOMYCIN; MORTALITY; MORBIDITY; IMPACT;
D O I
10.1016/j.medcli.2011.05.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: To include a specific antibiotic in the empiric therapy, it is necessary to predict when a nosocomial pneumonia (NP) is caused by methicillin-resistant Staphylococcus aureus (MRSA). We have developed a model for the prediction of the probability of a NP being caused by MRSA, when the carrier status and the microbiological diagnosis are unknown. Patients and methods: A retrospective case-control study (1999-2005) was designed. A univariate and multivariate logistic regression was performed to identify the risk factors for suffering a NP due to MRSA. Demographic factors, related to hospitalization, immunosuppression or neutropenia, to medication and severity were included. Results: Three hundred and sixty three patients (121 cases and 242 controls) were studied. The final model of multivariate logistic regression included an age > 14 years (OR 7.4, CI 95% 1.5-37.4, P < .015), NP appearance > 6 days after admittance (OR 4.1, CI 95% 2.4-7,1, P < .001), NP development excluding summers (OR 2.5, CI 95% 1.2-5.2, P < .015), respiratory diseases (OR 4.9, CI 95% 1.5-15.8, P < .007) and multilobar involvement (OR 4, CI 95% 2.3-7.2, P < .001). The probability of developing a pneumonia due to MRSA was studied for each of the possible combinations and subsequently classified in minor and major criteria. Conclusions: MRSA coverage should be included in the empirical treatment of NP when: a) an adult patient (> 14 years old) presents, at least, 2 major criteria or 1 major criterion together with 2 minor criteria, and b) a patient < 14 years-old has 2 major criteria as well as 2 minor criteria. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 50 条
  • [1] Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Thamlikitkul, Visanu
    Tongsai, Sasima
    [J]. CHEST, 2012, 142 (01) : 269 - 270
  • [2] Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia
    Segarra-Newnham, Marisel
    Church, Timothy J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1678 - 1687
  • [3] Pneumonia caused by methicillin-resistant Staphylococcus aureus
    Rubinstein, Ethan
    Kollef, Marin H.
    Nathwani, Dilip
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S378 - S385
  • [4] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
  • [5] Risk factors for ICU-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus
    Pereira, J
    Alba, M
    Cardoso, A
    Correia, R
    Silva, M
    Paiva, J
    Sousa-Dias, C
    Aguiar, L
    Barbosa, S
    Gomes, J
    Honrado, T
    Maia, I
    Massada, S
    Rios, M
    Mota, A
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 : S192 - S192
  • [6] Predictors of the pathogenicity of methicillin-resistant Staphylococcus aureus nosocomial pneumonia
    Nagaoka, Kentaro
    Yanagihara, Katsunori
    Harada, Yosuke
    Yamada, Koichi
    Migiyama, Yohei
    Morinaga, Yoshitomo
    Izumikawa, Koichi
    Kakeya, Hiroshi
    Yamamoto, Yoshihiro
    Nishimura, Masaharu
    Kohno, Shigeru
    [J]. RESPIROLOGY, 2014, 19 (04) : 556 - 562
  • [7] The economic impact of nosocomial methicillin-resistant Staphylococcus aureus pneumonia
    Ott, E.
    Graf, K.
    Schwab, F.
    Reichardt, C.
    Chaberny, I. F.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 27 - 27
  • [8] Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia
    Hall, Ronald G., II
    [J]. CHEST, 2007, 132 (03) : 1100 - 1101
  • [9] Necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus
    Hiramatsu, Toshiki
    Tobino, Kazunori
    [J]. CLINICAL CASE REPORTS, 2022, 10 (03):
  • [10] Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine
    Adwan, K
    Abu-Hasan, N
    Adwan, G
    Jarrar, N
    Abu-Shanab, B
    Abu-Zant, A
    [J]. MICROBIAL DRUG RESISTANCE, 2005, 11 (01) : 75 - 77